Europe Amniotic Membrane Market Analysis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE AMNIOTIC MEMBRANE MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES MODEL

5 EUROPE AMNIOTIC MEMBRANE MARKET: REGULATIONS

5.1 REGULATIONS IN EUROPE

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISE IN THE NUMBER OF ACCIDENTS, BURN INJURIES, AND TRAUMA CASES

6.1.2 INCREASE IN USE OF AMNIOTIC MEMBRANE IN OPTHALMOLOGY

6.1.3 BENEFITS ASSOCIATED WITH THE USE OF AMNIOTIC MEMBRANE

6.2 RESTRAINTS

6.2.1 LIMITATIONS OF AMNIOTIC MEMBRANE

6.2.2 STRINGENT GOVERNMENT REGULATIONS

6.3 OPPORTUNITIES

6.3.1 INCREASE IN DEMAND FOR STEM CELL RESEARCH & REGENERATIVE MEDICINE

6.3.2 INCREASE IN THE NUMBER OF SURGERIES

6.4 CHALLENGES

6.4.1 HIGH COST OF TREATMENT

6.4.2 LACK OF SKILLED PROFESSIONALS TO PERFORM AMNIOTIC MEMBRANE TRANSPLANTATION

6.4.3 COMPLICATIONS ASSOCIATED WITH THE USE OF AMNIOTIC MEMBRANES

7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY CHAIN

7.4 STRATEGIC DECISIONS FOR MANUFACTURERS

7.5 CONCLUSION

8 EUROPE AMNIOTIC MEMBRANE MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 DEHYDRATED AMNIOTIC MEMBRANES

8.3 CRYOPRESERVED AMNIOTIC MEMBRANES

8.4 OTHERS

9 EUROPE AMNIOTIC MEMBRANE MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 SURGICAL WOUNDS

9.3 OPHTHALMOLOGY

9.4 OTHERS

10 EUROPE AMNIOTIC MEMBRANE MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 AMBULATORY SURGICAL CENTERS

10.4 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES

10.5 SPECIALTY CLINICS

11 EUROPE AMNIOTIC MEMBRANE MARKET, BY COUNTRY

11.1 GERMANY

11.2 FRANCE

11.3 U.K.

11.4 ITALY

11.5 RUSSIA

11.6 SPAIN

11.7 SWITZERLAND

11.8 NETHERLANDS

11.9 BELGIUM

11.1 TURKEY

11.11 REST OF EUROPE

12 EUROPE AMNIOTIC MEMBRANE MARKET MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SOWT ANALYSIS

14 COMPANY PROFILE

14.1 ORGANOGENESIS, INC

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENT

14.2 MIMEDX

14.2.1 COMPANY SNAPSHOT

14.2.2 RECENT FINANCIALS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENT

14.3 SMITH & NEPHEW PLC

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENTS

14.4 AMNIO TECHNOLOGY, LLC

14.4.1 COMPANY SNAPSHOT

14.4.2 PRODUCT PORTFOLIO

14.4.3 RECENT DEVELOPMENTS

14.5 AMNIOX MEDICAL, INC.

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENTS

14.6 AN-VISION

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 APPLIED BIOLOGICS

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 ARTHREX, INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 INTEGRA LIFESCIENCES

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENTS

14.1 KATENA PRODUCTS, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 NUVISION BIOTHERAPIES LTD

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 SKYE BIOLOGICS HOLDINGS, LLC

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENT

14.13 STRYKER

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLI0

14.13.4 RECENT DEVELOPMENT

14.14 THE ELECTROSPINNING COMPANY

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 WWW.SURGILOGIX.COM

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS